LDL size and risk of coronary heart disease in elderly men and women

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 11, 1999, Pages 2742-2748

  Mykkänen, Leena ^a,b   Kuusisto, Johanna ^b   Haffner, Steven M ^a   Laakso, Markku ^b   Austin, Melissa A ^c  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Coronary heart disease; Epidemiology; LDL; Lipoproteins; Prospective study

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY RISK; FEMALE; GEL ELECTROPHORESIS; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PARTICLE SIZE; PHENOTYPE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 0032741929     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.11.2742     Document Type: Article

References (42)

1. Kannel W, Castelli WP, Gordon T, McNamara PM. Serum cholesterol, lipoproteins and the risk of coronary heart disease: the Framingham Study. Ann Intern Med. 1971;74:1-12.
2. Stamler J, Wentworth D, Neaton JD, for the MRFIT Research Group. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? findings in 356 222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA. 1986;256:2823-2828.
3. Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res. 1981;23:236-244.
4. Swinkels DW, Hak-Lemmers HLM, Demacker PNM. Single spin density gradient ultracentrifugation method for the detection and isolation of light and heavy low density lipoprotein subfractions. J Lipid Res. 1987;28:1233-1239.
5. Austin MA, Breslow JL, Hennekens CH, During JL, Willett WC, Krauss RM. Low density lipoprotein subclass pattern and risk of myocardial infarction. JAMA. 1988;260:1917-1921.
6. Crouse JR, Parks JS, Schey HM, Kahl FT. Studies of low density lipoprotein molecular weight in human beings with coronary artery disease. J Lipid Res. 1985;26:566-574.
7. Campos H, Genest JJ, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM, Wilson PWF, Schaefer EJ. Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb. 1992;12:187-195.
8. Tornvall P, Karpe F, Carlson LA, Hamsten A. Relationships of low density lipoprotein subfractions to angiographically defined coronary heart disease in young survivors of myocardial infarction. Atherosclerosis. 1991;90:67-80.
9. Coresh J, Kwiterovich PO Jr, Smith HH, Bachorik PS. Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women. J Lipid Res. 1993;34:1687-1697.
10. Gardner CD, Fortmann SP, Krauss RM. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA. 1996;276:875-881.
11. Stampfer MJ, Krauss RM, Ma J, Blanche PJ, Holl LG, Sacks FM, Hennekens CH. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA. 1996;276:882-888.
12. Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Després J-P. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men: prospective results from the Québec Cardiovascular Study. Circulation. 1997;95:69-75.
13. Austin MA, Mykkänen L, Kuusisto J, Edwards KL, Nelson C, Haffner SM, Pyörälä K, Laakso M. Prospective study of small LDLs as a risk factor for non-insulin dependent diabetes mellitus in elderly men and women. Circulation. 1995;92:1770-1778.
14. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes. 1994;43:960-967.
15. Mykkänen L, Laakso M, Uusitupa M, Pyörälä K. Prevalence of diabetes and impaired glucose tolerance in elderly subjects and their association with obesity and family history of diabetes. Diabetes Care. 1990;13:1099-1105.
16. Mykkänen L, Laakso M, Penttilä I, Pyörälä K. Asymptomatic hyperglycemia and cardiovascular risk factors in the elderly. Atherosclerosis. 1991;88:153-161.
17. World Health Organization. Diabetes Mellitus: Report of a WHO Study Group. Geneva, Switzerland: World Health Organization; 1985. Technical report series No. 727.
18. Prineas RJ, Crow RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings: Standards and Procedures for Measurement and Classification. Boston, Mass: Wright; 1982.
19. World Health Organization. MONICA Manual: CVD/MNC. Geneva, Switzerland: World Health Organization; 1990.
20. Tuomilehto J, Arstila M, Kaarsalo E, Kankaanpää J, Ketonen M, Kuulasmaa K, Lehto S, Miettinen H, Mustaniemi H, Palomäki P, Puska P, Pyörälä K, Salomaa V, Torppa J, Vuorenmaa T. Acute myocardial infarction (AMI) in Finland: baseline data from the FINMONICA AMI Register in 1983-85. Eur Heart J. 1992;13:577-587.
21. Penttilä I, Voutilainen E, Laitinen P, Juutilainen P. Comparison of different analytic and precipitation methods for direct estimation of scrum high-density lipoprotein cholesterol. Scand J Clin Lab Invest. 1981;41:353-360.
22. Fruchart J-C, Kora I, Cachera C, Clavey V, Duthilleul P, Moschetto Y. Simultaneous measurements of plasma apolipoproteins A-1 and B by electroimmunoassay. Clin Chem. 1982;28:59-62.
23. McNamara JR, Campos H, Ordovas JM, Wilson PWF, Schaefer EJ. Gradient gel electrophoretic analysis of low density lipoproteins. Am Biotech Lab. 1988;6:28-33.
24. Dormans TPJ, Swinkels DW, De Graaf J, Hendriks JCM, Stalenhoef AFP, Demacker PNM. Single-spin density-gradient ultracentrifugation vs. gradient gel electrophoresis: two methods for detecting low-density-lipoprotein heterogeneity compared. Clin Chem. 1991;37:853-858.
25. Hokanson JE, Austin MA, Zambon A, Brunzell JD. Plasma triglyceride and LDL heterogeneity in familial combined hyperlipidemia. Arterioscler Thromb. 1993;13:427-434.
26. Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low-density lipoprotein in normal humans. J Lipid Res. 1982;23:97-104.
27. Brown BW, Brauner C, Chan A, Gutierrez D, Herson J, Lovato J, Polsley J, Russell K. STPLAN. version 4.1. Houston, Tex: Department of Biomathematics, University of Texas, AID Anderson Cancer Center; 1996:101-106.
28. Brown BW, Brauner C, Chan A, Gutierrez D, Herson J, Lovato J, Polsley J, Russell K. STPLAN. version 4.1. Houston, Tex: Department of Biomathematics, University of Texas, MD Anderson Cancer Center; 1996:31-34.
29. Mykkänen L, Haffner SM, Rainwater DL, Karhapää P, Miettinen H, Laakso M. Relationship of LDL size to insulin sensitivity in normoglycemic men. Arterioscler Thromb Vasc Biol. 1997;17:1447-1453.
30. Selby JV, Austin MA, Newman B, Zhang D, Quesenberry CP Jr, Mayer EJ, Kraus RM. LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation. 1993;88:381-387.
31. Feingold KR, Grunfeld C, Pang M, Coerrler W, Krauss RM. LDL subclass phenotypes and triglyceride in non-insulin-dependent diabetes. Arterioscler Thromb. 1992;12:1496-1502.
32. Haffner SM, Mykkänen L, Stern MP, Paidi M, Howard BV. Greater effect of diabetes on LDL size in women than in men. Diabetes Care. 1994;17:1164-1171.
33. Gray RS, Robbins DC, Wang W, Yeh JL, Fabsitz RR, Cowan LD, Welty TK, Lee ET, Krauss RM, Howard BV. Relation of LDL size to the insulin resistance syndrome and coronary heart disease in American Indians: the Strong Heart Study. Arterioscler Thromb Vasc Biol. 1997;17:2713-2720.
34. Laakso M, Lehto S. Epidemiology of macrovascular disease in diabetes. Diabetes Rev. 1997;5:294-315.
35. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study. Am J Med. 1977;62:707-714.
36. Castelli WP, Wilson PWF, Levy D, Anderson K. Cardiovascular risk factors in the elderly. Am J Cardiol. 1989;63:12H-19H.
37. Benfante R, Reed D. Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly? JAMA. 1990;263:393-396.
38. Zimetbaum P, Frishman WH, Ooi WL, Derman MP, Aronson M, Gidez LI, Eder HA. Plasma lipids and lipoproteins and the incidence of cardiovascular disease in the very elderly. Arterioscler Thromb. 1992;12:416-423.
39. Corti M-C, Guralnik JM, Salive ME, Harris T, Field TS, Wallace RB, Berkman LF, Seeman TE, Glynn RJ, Hennekens CH, Havlik RJ. HDL cholesterol predicts coronary heart disease mortality in older persons. JAMA. 1995;274:539-544.
40. Vokonas PS, Kannel WB, Cupples LA. Epidemiology and risk of hypertension in the elderly: the Framingham Study. J Hypertens. 1988;6(suppl 1):S3-S9.
41. Jajich CL, Ostfeld AM, Freeman DH. Smoking and coronary heart disease mortality in the elderly. JAMA. 1984;252:2831-2834.
42. LaCroix AZ, Lang J, Scherr P, Wallace RB, Cornoni-Huntley J, Berkman L, Curb JD, Evans D, Hennekens CH. Smoking and mortality among older men and women in three communities. N Engl J Med. 1991;324:1619-1625.